Vijaya Diagnostic Centre Ltd

Q1 FY26Healthcare Services

Vijaya Diagnostic Centre Ltd Q1 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,504

Market cap₹14.3K Cr

P/E82.7

Updated23 Aug 2026

Read4 min read

The short version

Vijaya Diagnostic targets consistent revenue growth of 15%+ annually, backed by about 13% volume growth. The company maintains a consistent revenue growth guidance of 15%+ annually, driven primarily by volume growth (~13%) and price increases (1.5%-2%).

From Vijaya Diagnostic Centre Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Vijaya Diagnostic targets consistent revenue growth of 15%+ annually, backed by about 13% volume growth.
Price increases contribute approximately 1.5% to 2% of the revenue growth.
Existing (old) centers are expected to continue growing test volumes by around 9%-10%.
New centers contribute the remaining volume growth, with rapid ramp-up seen in newly entered markets like East India and Bangalore.
The company aims to expand revenue in new geographies (e.g., East India) to Rs. 50-100 crore within 2-3 years through opening hubs and spokes.
Growth is driven by market share gains, increased patient footfalls, and expansion into new regions.

2 more points management made on revenue & sales performance

Profitability & Margins

The company maintains a consistent revenue growth guidance of 15%+ annually, driven primarily by volume growth (~13%) and price increases (1.5%-2%).
Earnings growth is supported by test volume growth; older centers are expected to grow volumes by 9%-10%, with the balance from new centers.
EBITDA margins are guided to be around 38%-38.5% for the full year, factoring in operating drags from new hub additions (~1%-1.5% margin impact).
New hubs are ramping up well, with break-even achieved generally at about 33% capacity utilization within the first 2-3 quarters.
Price increases are possible but selectively applied; no broad price hikes planned for the current financial year beyond Q1.

2 more points management made on profitability & margins

See what Vijaya Diagnostic Centre Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

For FY26, guided overall CAPEX for new centers is around Rs. 150-155 crores.
Replacement CAPEX expected at 2%-3% of overall topline.
Five new hubs have been commissioned in the current quarter; five more hubs planned for the next two quarters.
Scouting for new locations across core and new geographies (including Bangalore, Kolkata, Pune) is ongoing.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹955 Cr

Rev 1Mar 1

2Chandan Healthca₹496 Cr

Rev 1Mar 3

3₹65.8K Cr

Rev 2Mar 1

4₹658 Cr

Rev 2Mar 2

5₹1.3L Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

There is no specific mention of any current or planned fundraising through debt or equity in the provided transcript.
The company discussed capital expenditure guidance for FY26, mentioning Rs. 150-155 crores for new centers and 2%-3% of overall topline for replacement CAPEX, indicating internal funding plans.
No explicit commentary on new debt or equity issuance was given during the Q&A or management commentary.

- The company appears focused on organic growth and expansion through adding hubs and spokes without discussing fresh fundraising at this time. - Cash position as of June 30, 2025, was strong at around Rs. 270 crores (net cash Rs. 220 crores), suggesting available internal liquidity to support growth. In summary, no current or future debt/equity fundraising plans were disclosed in the July 28, 2025 call transcript.

2 more points management made on fundraising & capital structure

See what Vijaya Diagnostic Centre Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript on page 17 of the Vijaya Diagnostic Center Limited earnings call does not explicitly mention "current" or "expected orderbook" or "pending orders." However, some relevant points related to capacity and expansion plans that might indirectly reflect the company's growth pipeline are: - The company has added several new hubs recently and plans to open more hubs—five hubs opened in the current quarter, with five more expected to open in the next two quarters. - Discussions about scouting locations for FY27 hub additions are ongoing, with clearer updates expected in the next earnings call.

2 more points management made on order book & pipeline

Vijaya Diagnostic Centre Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹219 Cr, net profit ₹48 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Vijaya Diagnost.'s management said in earlier quarters

Others in Healthcare Services this season

Aster DM Quality (Q1 FY26)
Recent quarters saw subdued volume growth due to leadership changes and seasonal effects, but an 8% volume growth was achieved in Q1 FY26, improving from 2% in…
Dr Agarwal's Hea (Q1 FY26)
70 crores via preferential allotment to AEHL for CAPEX plans, particularly the flagship facility at Cathedral Road, indicating capacity and service…
Syngene International Ltd (Q1 FY26)
Operating EBITDA grew 21% YoY in Q1 FY '26 with margins rising to ~24% from 22% last year. Key concall takeaways from Syngene International Ltd's Q1 FY26…
Yatharth Hospital & Trauma Care Services Ltd (Q1 FY26)
International patient business is growing but will remain around 10% of revenue, positively impacting ARPOB without hurting margins. Key concall takeaways from…

Compare:vs Apollo Hospitals vs Max Healthcare Institute Ltd vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Vijaya Diagnostic Centre Ltd Q1 FY26 results?

What is Vijaya Diagnostic Centre Ltd share price analysis?

Vijaya Diagnostic Centre Ltd currently shows a neutral. The stock trades at a P/E of 82.7 with a market cap of ₹14,313 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vijaya Diagnostic Centre Ltd planning capital expenditure?

For FY26, guided overall CAPEX for new centers is around Rs.

Keep Vijaya Diagnostic Centre Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.